Clinical Trials Directory

Trials / Completed

CompletedNCT03018548

Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To monitor changes in indicators of red cell damage such as extracellular hemoglobin, potassium (K-ABL), and lactate dehydrogenase (LD) post blast exposure.

Detailed description

Traumatic brain injury (TBI) causes significant morbidity and mortality, accompanied by high related costs. Recent hypotheses concerning the pathophysiology of TBI invoke Strain Shear Theory and Cavitation Theory. The invbestigators propose to test the importance of the latter by directing blast waves into containers that are either partially or completely filled with blood and measuring markers of lysis. These experiments are designed to better understand the demonstrated effectiveness of mild jugular compression according to the principle of the Queckenstedt Maneuver to reduce the likelihood of TBI by filling up the compliance of the cranial space. A device (C-Collar) is being developed by Q30 Labs, LLC (Q30), to accomplish this effect.

Conditions

Interventions

TypeNameDescription
OTHERblood drawsubjects will have blood drawn done. This blood will then be exposed to blasting with CO2 cartridge

Timeline

Start date
2016-01-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2017-01-12
Last updated
2020-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03018548. Inclusion in this directory is not an endorsement.